SAFETY AND EFFECTIVENESS OF THE DRUG DPC 083 IN COMBINATION WITH NUCLEOSIDE ANALOGUE REVERSE TRANSCRIPTASE INHIBITORS IN HIV-1-INFECTED PATIENTS WHO ARE FAILING TREATMENT WITH NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS: